U.S. market Closed. Opens in 22 hours 48 minutes

PRTK | Paratek Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue150.79M120.95M43.52M16.54M17.12M12.62M29.00KN/A4.34M1.75M11.03M19.69M12.50M5.21M60.62M16.68M371.00K56.00K1.12M1.33M371.00KN/A
Cost of Revenue23.06M21.54M8.65M3.48MN/AN/AN/AN/AN/AN/AN/AN/A1.97M2.22MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit127.73M99.42M34.87M13.06M17.12M12.62M29.00KN/A4.34M1.75M11.03M19.69M10.53M2.98M60.62M16.68M371.00K56.00K1.12M1.33M371.00KN/A
Operating Expenses173.94M140.55M110.37M128.69M121.17M97.04M109.86M70.75M10.86M26.16M22.88M23.46M21.72M25.05M28.58M53.33M33.12M24.92M19.90MN/A6.25M1.65M
Selling, General & Admin145.60M119.40M89.86M89.14M63.66M36.97M26.40M19.99M5.85M19.25M11.69M12.19M11.04M16.05M16.90M17.28M11.31M7.25M5.21MN/A2.21M602.00K
Research & Development37.82M30.35M23.92M39.55M57.51M60.07M83.46M50.77M5.01M6.90M11.19M11.27M10.68M9.01M11.68M36.05M21.81M17.67M14.69MN/A4.04M1.04M
Other Operating Expenses-9.48M-9.21M-3.41M-31.00K-44.00K-34.00K4.00K-37.00K-299.00K2.96MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-46.21M-41.13M-75.50M-115.63M-104.08M-84.58M-109.49M-70.05M-7.80M-27.37M-11.86M-3.76M-9.22M-22.07M32.04M-36.65M-32.74M-24.86M-18.78M1.33M-5.88M-1.65M
Other Expenses / Income-17.30M-17.35M-21.04M-12.86M-7.77M-3.74M-2.15M-807.00K-10.04M-75.00K-159.00K-116.00K-81.00K271.00K2.78M4.12M3.12MN/AN/AN/AN/AN/A
Before Tax Income-63.51M-58.48M-96.54M-128.49M-111.85M-88.32M-111.64M-70.86M-17.84M-27.45M-12.02M-3.95M-9.42M-24.13M34.82M-32.53M-29.63MN/AN/AN/AN/AN/A
Income Tax Expenses57.00K600.00K19.72M301.00K502.00K753.00K3.23M19.00K419.00K2.95M-229.00K-427.00K81.00K1.40M-2.78M-4.12M-3.12M-1.06M-827.00K12.78M5.64M1.58M
Net Income-63.57M-59.08M-116.26M-128.79M-112.36M-89.07M-111.64M-70.86M-17.84M-27.45M-12.02M-3.88M-9.30M-21.80M34.82M-32.53M-29.63M-23.80M-17.95M-12.78M-5.64M-1.58M
Interest Expenses18.12M17.41M20.24M16.40M10.98M5.08M3.22M770.00K718.00KN/AN/A9.00K12.00K179.00KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding54.39M48.42M44.17M32.79M31.51M26.83M20.25M16.50M2.53M1.56M1.42M1.13M1.12M1.01M33.42K80.53K249.85K23.30K18.07K15.05K13.58K11.80K
Diluted Shares Outstanding54.39M48.42M44.17M32.79M31.51M26.83M20.25M16.50M2.53M1.56M1.42M1.13M1.12M1.01M33.42K80.53K249.85K23.30K18.07K15.05K13.58K11.80K
EBITDA-44.90M-40.69M-73.93M-112.09M-100.83M-83.08M-106.45M-70.79M-6.62M-21.45M-11.86M-3.76M-8.53M-17.79M33.16M-36.13M-32.05M-24.34M-18.69M1.33M-5.88M-1.65M
EBITDA Margin-29.78%-33.64%-169.89%-677.50%-589.08%-658.51%-367,086.21%0.00%-152.53%-1,227.65%-107.54%-19.11%-68.21%-341.61%54.71%-216.60%-8,639.08%-43,469.64%-1,668.84%100.00%-1,584.37%0.00%
EBIT-45.39M-41.08M-76.30M-112.09M-100.87M-83.24M-105.19M-70.07M-16.70M-24.50M-12.24M-4.30M-9.21M-20.22M32.04M-36.65M-32.74M-24.86M-18.78MN/AN/AN/A
EBIT Margin-30.10%-33.96%-175.34%-677.50%-589.29%-659.77%-362,710.34%0.00%-384.57%-1,402.35%-111.06%-21.82%-73.68%-388.21%52.86%-219.69%-8,825.88%-44,400.00%-1,676.70%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙